Marshall Wace’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.4M | Buy |
+144,500
| New | +$12.7M | 0.01% | 945 |
|
|
2026
Q1 | – | Sell |
-7,245
| Closed | -$651K | – | 3741 |
|
|
2025
Q4 | $651K | Sell |
7,245
-294,725
| -98% | -$27.9M | ﹤0.01% | 2130 |
|
|
2025
Q3 | $29.7M | Buy |
301,970
+52,487
| +21% | +$5.2M | 0.03% | 497 |
|
|
2025
Q2 | $22.8M | Sell |
249,483
-98,367
| -28% | -$9.51M | 0.03% | 542 |
|
|
2025
Q1 | $39.4M | Buy |
+347,850
| New | +$37.2M | 0.05% | 336 |
|
|
2024
Q3 | – | Sell |
-56,000
| Closed | -$6.08M | – | 3024 |
|
|
2024
Q2 | $6.08M | Buy |
+56,000
| New | +$6.6M | 0.01% | 928 |
|
|
2023
Q4 | – | Sell |
-153,159
| Closed | -$17.2M | – | 2673 |
|
|
2023
Q3 | $17.2M | Buy |
153,159
+109,559
| +251% | +$13.9M | 0.03% | 487 |
|
|
2023
Q2 | $6.35M | Sell |
43,600
-115,655
| -73% | -$15.7M | 0.01% | 921 |
|
|
2023
Q1 | $20.6M | Buy |
159,255
+153,676
| +2,755% | +$19.3M | 0.04% | 460 |
|
|
2022
Q4 | $711K | Buy |
+5,579
| New | +$647K | ﹤0.01% | 2221 |
|
|
2022
Q1 | – | Sell |
-10,245
| Closed | -$1.26M | – | 4128 |
|
|
2021
Q4 | $1.26M | Sell |
10,245
-57,491
| -85% | -$7.52M | ﹤0.01% | 2355 |
|
|
2021
Q3 | $9.63M | Buy |
67,736
+42,327
| +167% | +$6.23M | 0.04% | 583 |
|
|
2021
Q2 | $3.97M | Sell |
25,409
-61,212
| -71% | -$9.92M | 0.02% | 983 |
|
|
2021
Q1 | $13.5M | Sell |
86,621
-120,417
| -58% | -$18.7M | 0.06% | 327 |
|
|
2020
Q4 | $31M | Buy |
207,038
+37,996
| +22% | +$5.37M | 0.17% | 121 |
|
|
2020
Q3 | $22.3M | Buy |
169,042
+38,110
| +29% | +$4.98M | 0.14% | 153 |
|
|
2020
Q2 | $15.2M | Sell |
130,932
-123,559
| -49% | -$14.2M | 0.11% | 204 |
|
|
2020
Q1 | $25M | Sell |
254,491
-147,095
| -37% | -$19.3M | 0.25% | 89 |
|
|
2019
Q4 | $58.4M | Buy |
401,586
+177,500
| +79% | +$24.5M | 0.4% | 45 |
|
|
2019
Q3 | $29.9M | Buy |
224,086
+60,089
| +37% | +$7.76M | 0.23% | 96 |
|
|
2019
Q2 | $18.7M | Buy |
163,997
+148,540
| +961% | +$17.4M | 0.15% | 139 |
|
|
2019
Q1 | $1.92M | Buy |
15,457
+10,898
| +239% | +$1.24M | 0.02% | 751 |
|
|
2018
Q4 | $459K | Sell |
4,559
-8,712
| -66% | -$980K | ﹤0.01% | 1135 |
|
|
2018
Q3 | $1.69M | Buy |
+13,271
| New | +$1.58M | 0.01% | 713 |
|
|
2017
Q2 | – | Sell |
-11,870
| Closed | -$1.41M | – | 397 |
|
|
2017
Q1 | $1.41M | Sell |
11,870
-706,699
| -98% | -$80.1M | 0.07% | 184 |
|
|
2016
Q4 | $72M | Buy |
718,569
+228,690
| +47% | +$24.5M | 0.47% | 44 |
|
|
2016
Q3 | $61.8M | Buy |
489,879
+470,826
| +2,471% | +$58.2M | 0.44% | 55 |
|
|
2016
Q2 | $2.23M | Buy |
19,053
+2,446
| +15% | +$277K | 0.02% | 561 |
|
|
2016
Q1 | $1.72M | Sell |
16,607
-6,409
| -28% | -$620K | 0.02% | 593 |
|
|
2015
Q4 | $2.29M | Sell |
23,016
-2,562
| -10% | -$251K | 0.02% | 535 |
|
|
2015
Q3 | $2.33M | Sell |
25,578
-128,839
| -83% | -$12.9M | 0.03% | 419 |
|
|
2015
Q2 | $16.4M | Buy |
+154,417
| New | +$17.1M | 0.21% | 123 |
|
|
2015
Q1 | – | Sell |
-75,523
| Closed | -$8.32M | – | 956 |
|
|
2014
Q4 | $8.32M | Buy |
75,523
+72,875
| +2,752% | +$7.68M | 0.11% | 223 |
|
|
2014
Q3 | $259K | Buy |
+2,648
| New | +$260K | ﹤0.01% | 732 |
|
|
2014
Q2 | – | Sell |
-6,285
| Closed | -$577K | – | 1089 |
|
|
2014
Q1 | $577K | Buy |
+6,285
| New | +$579K | 0.01% | 566 |
|
Other funds holding ZBH
Marshall Wace's ZBH Position: Q2 2026 in Review
Marshall Wace opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 144,500 shares worth $12.4M. The stake represents 0.01% of the portfolio and ranks #945 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ZBH as recently as Q4 2025.
Marshall Wace first reported a position in ZBH in Q1 2014 and has held it in 35 quarters since. The position peaked at $72M in Q4 2016. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Marshall Wace held 144,500 shares of Zimmer Biomet worth $12.4M as of Q2 2026.
- Zimmer Biomet was a new Marshall Wace position in Q2 2026.
- Zimmer Biomet made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #945 holding.
- Marshall Wace first reported a position in Zimmer Biomet in Q1 2014 and has held it in 35 quarters since.
- Marshall Wace's Zimmer Biomet position peaked at $72M in Q4 2016.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.